Gypto Pharma, which recently opened in Cairo, is seeking to transform Egypt into a regional pharmaceutical hub.
“We are building a strategic road map on establishing a regional pharmaceutical hub of excellence for multi-national companies.”
“We are targeting export as a key milestone in our journey,” said Amre Mamdouh, chairman and CEO of Gypto Pharma.
Achieving medical security, attracting international companies and localizing the pharmaceutical industry are among their core goals, he added.
Inaugurated in April and located in Qalyubia province, north of Cairo, “Medicine City covers an area of 180,000 square meters.
It is equipped with advanced technologies and systems in pharmaceutical production to attract major international companies in the field.
The current phase covers an area of 120,000 square meters and it includes buildings for traditional medicine production, administration, industrial services and networks, the chairman said.
The future phase covers an area of 60,000 square meters as it includes factories producing biosimilars, oncology medications, Beta-Lactam antibiotics, hormone drugs and vaccines.
The traditional medicine-related premises include a factory for solid preparations production lines for tablets, capsules, sachets, and effervescent, powder formulations.
There is also a factory for semi-solid preparation that includes production lines for ointments, creams, suppositories, and gelatin capsules.
Additionally, the premises include a factory for liquid preparations that contains production lines for syrups and oral drops.
Moreover, there is a factory for sterile preparations that includes production lines for ophthalmic drops, dental anesthetics, ampoules, and intravenous fluids.
